Results 11 to 20 of about 22,097 (178)

Study of the teratogenicity of the vaccine strain of the Rubella virus «Orlov-V» (Matonaviridae: Rubivirus: Rubella virus) in experience on rhesus macaques

Вопросы вирусологии, 2021
Introduction. Rubella virus has pronounced teratogenic properties that can cause generalized and persistent intrauterine infection of the fetus. As a result, the control of the loss of teratogenicity inherent in «wild-type» virus strains is a necessary ...
I. N. Lavrentjeva, O. A. Shamsutdinova, I. I. Chugueva, D. D. Karal-ogly, O. I. Vyshemirskiy   +4 more
doaj   +1 more source

The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015

Vaccines, 2022
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years.
Ravit Bassal, Tamy Shohat, Tal Levin, Rakefet Pando, Eilat Shinar, Doron Amichay, Mira Barak, Anat Ben-Dor, Adina Bar-Haim, Ella Mendelson, Dani Cohen, Lital Keinan-Boker, Victoria Indenbaum   +12 more
doaj   +1 more source

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries

Papillomavirus Research, 2019
Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000.
Asmaa Gohar, Nourtan F. Abdeltawab, Nahla Shehata, Magdy A. Amin   +3 more
doaj   +1 more source

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda

BMC Infectious Diseases, 2020
Background Control of Rubella and Congenital Rubella Syndrome using vaccination has shown great success in the America’s. Uganda is due to introduce the Rubella vaccine however the magnitude of transmission is not well documented.
Fred Bagenda, Edgar Mugema Mulogo, Richard Onyuthi Apecu, Anette Kisakye, Benard Toliva Opar   +4 more
doaj   +1 more source

Biological properties of domestic strain vRub-Ant of rubella virus

Журнал микробиологии, эпидемиологии и иммунобиологии, 2022
Introduction. Rubella is a mild infectious disease affecting mainly children and is caused by the rubella virus, part of the Matonoviridae family, genus Rubivirus.
Firaya G. Nagieva, Elena P. Barkova, Alexandra D. Stroeva, Yulia I. Ammur, Alexander V. Sidorov, Olga S. Kharchenko, Georgy N. Bukhtoyarov, Oksana A. Svitich, Vitaly V. Zverev   +8 more
doaj   +1 more source

Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.

PLoS ONE, 2022
The Democratic Republic of the Congo (DRC) has a high measles incidence despite elimination efforts and has yet to introduce rubella vaccine. We evaluated the performance of a prototype rapid digital microfluidics powered (DMF) enzyme-linked immunoassay (
Alaine K Knipes, Aimee Summers, Alexandros A Sklavounos, Julian Lamanna, Richard P S de Campos, Tanya Narahari, Christopher Dixon, Ryan Fobel, Yassa D Ndjakani, Leopold Lubula, Alain Magazani, Jean Jacques Muyembe, Yvonne Lay, Elizabeth Pukuta, Diane Waku-Kouomou, Lijuan Hao, Jolie Kasongo Kayembe, Christian Fobel, Joshua Dahmer, Adam Lee, Man Ho, Jose Gilberto Camacho Valenzuela, Darius G Rackus, Roger Shih, Brendon Seale, Ann Chang, Gilson Paluku, Paul A Rota, Aaron R Wheeler, Heather M Scobie   +29 more
doaj   +1 more source

Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.

PLoS ONE, 2018
BackgroundMeasles outbreaks have occurred in some countries despite supplementary immunization activities (SIA) using measles-containing vaccine with high vaccination coverage.
Masahiko Hachiya, Shinsuke Miyano, Yoshio Mori, Emilia Vynnycky, Phath Keungsaneth, Phengta Vongphrachanh, Anonh Xeuatvongsa, Thongchanh Sisouk, Vilasak Som-Oulay, Bouaphan Khamphaphongphane, Bounthanom Sengkeopaseuth, Chansay Pathammavong, Kongxay Phounphenghak, Tomomi Kitamura, Makoto Takeda, Katsuhiro Komase   +15 more
doaj   +1 more source

Childhood MMR Vaccination Effectiveness Against Rubella: A Longitudinal Cohort Study

Global Pediatric Health, 2022
The vaccine effectiveness (VE) of childhood measles-mumps-rubella (MMR) vaccine to reduce childhood rubella infections in the US during the 1990s/2000s was undertaken in a retrospective longitudinal cohort study.
David A. Geier BA, Mark R. Geier MD, PhD, FACE   +1 more
doaj   +1 more source

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

Эпидемиология и вакцинопрофилактика, 2021
Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov   +9 more
doaj   +1 more source

Modeling the dynamics of rubella disease with vertical transmission

Heliyon, 2022
Rubella is a highly contagious and serious human disease caused by the rubella virus. It affects everyone around the world, but it is especially common in pregnant women and children. In particular, when pregnant women are infected with the rubella virus,
Getachew Teshome Tilahun, Tariku Merga Tolasa, Getinet Alemayehu Wole   +2 more
doaj   +1 more source